Literature DB >> 10048922

Structural basis for HLA-DQ binding by the streptococcal superantigen SSA.

E Sundberg1, T S Jardetzky.   

Abstract

Streptococcal superantigen (SSA) is a 28,000 Mr toxin originally isolated from a pathogenic strain of Streptococcus pyogenes that has 60% sequence identity with staphylococcal enterotoxin B (SEB). SSA and SEB, however, do not compete for binding on the surfaces of cells expressing MHC class II molecules. This behavior had been ascribed to SSA and SEB binding to distinct sites on, or different subsets of, HLA-DR molecules. Here we demonstrate that SSA binds predominantly to HLA-DQ, rather than to HLA-DR molecules, and present the crystal structure of SSA at 1.85 A resolution. These data provide a structural basis for interpreting the interaction of SSA with HLA-DQ molecules as well as a foundation for understanding bacterial superantigen affinities for distinct MHC isotypes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10048922     DOI: 10.1038/5809

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  10 in total

1.  Crystal structure of staphylococcal enterotoxin I (SEI) in complex with a human major histocompatibility complex class II molecule.

Authors:  Marisa M Fernández; Rongjin Guan; Chittoor P Swaminathan; Emilio L Malchiodi; Roy A Mariuzza
Journal:  J Biol Chem       Date:  2006-07-06       Impact factor: 5.157

2.  Mutagenesis, biochemical, and biophysical characterization of Mycoplasma arthritidis-derived mitogen.

Authors:  Hongmin Li; Yiwei Zhao; Yi Guo; Sandra J Vanvranken; Zhong Li; Leslie Eisele; Walid Mourad
Journal:  Mol Immunol       Date:  2006-06-05       Impact factor: 4.407

Review 3.  A decade of molecular pathogenomic analysis of group A Streptococcus.

Authors:  James M Musser; Samuel A Shelburne
Journal:  J Clin Invest       Date:  2009-09       Impact factor: 14.808

4.  Crystal structure of staphylococcal enterotoxin G (SEG) in complex with a mouse T-cell receptor {beta} chain.

Authors:  Marisa M Fernández; Sangwoo Cho; Mauricio C De Marzi; Melissa C Kerzic; Howard Robinson; Roy A Mariuzza; Emilio L Malchiodi
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

5.  Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen.

Authors:  J K McCormick; A A Pragman; J C Stolpa; D Y Leung; P M Schlievert
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

6.  Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity.

Authors:  Stephanie Ascough; Rebecca J Ingram; Karen K Chu; Catherine J Reynolds; Julie A Musson; Mehmet Doganay; Gökhan Metan; Yusuf Ozkul; Les Baillie; Shiranee Sriskandan; Stephen J Moore; Theresa B Gallagher; Hugh Dyson; E Diane Williamson; John H Robinson; Bernard Maillere; Rosemary J Boyton; Daniel M Altmann
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

7.  Elevated risk of invasive group A streptococcal disease and host genetic variation in the human leucocyte antigen locus.

Authors:  Tom Parks; Katherine Elliott; Theresa Lamagni; Kathryn Auckland; Alexander J Mentzer; Rebecca Guy; Doreen Cartledge; Lenka Strakova; Daniel O' Connor; Andrew J Pollard; Matthew J Neville; Anubha Mahajan; Houman Ashrafian; Stephen J Chapman; Adrian V S Hill; Shiranee Sriskandan; Julian C Knight
Journal:  Genes Immun       Date:  2019-08-29       Impact factor: 2.676

Review 8.  The contribution of group A streptococcal virulence determinants to the pathogenesis of sepsis.

Authors:  Mark Reglinski; Shiranee Sriskandan
Journal:  Virulence       Date:  2013-10-09       Impact factor: 5.882

Review 9.  Molecular and genomic characterization of pathogenic traits of group A Streptococcus pyogenes.

Authors:  Shigeyuki Hamada; Shigetada Kawabata; Ichiro Nakagawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2015       Impact factor: 3.493

Review 10.  Streptococcal toxic shock syndrome in the intensive care unit.

Authors:  Marylin Schmitz; Xavier Roux; Benedikt Huttner; Jérôme Pugin
Journal:  Ann Intensive Care       Date:  2018-09-17       Impact factor: 6.925

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.